Back to Results
First PageMeta Content



# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,*,#, Stephen M. Shaw 1,*, Kim Wi
Add to Reading List

Document Date: 2017-03-27 02:02:40


Open Document

File Size: 915,67 KB

Share Result on Facebook